Clinical Trials Browser

Phase 4 × Isotretinoin × Clear all

NCT06047535 2023-09-21

Naxitamab and Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF) Combined With Isotretinoin for Maintenance Treatment of Patients With High-Risk Neuroblastoma in First Complete Response.

Phase 4 Not yet recruiting

Neuroblastoma

NCT04864717 2021-09-08

Doxycycline vs Isotretinoin for Acneiform Eruptions of TKI

Phase 4 Unknown

Neoplasms, Second Primary, Acneiform Eruptions